Generated by AI
ICON plc is a clinical research organisation that provides outsourced drug and device development services to pharmaceutical, biotechnology, medical device, and public health customers. The company supports clinical development across the full product lifecycle, including study design, trial management, data solutions, site and patient access, laboratory services, and commercialization support. ICON plc also offers consulting and advisory capabilities, decentralized and hybrid trial services, real-world intelligence, and therapeutic expertise across areas such as oncology, cardiology, infectious disease, immunology, and central nervous system disorders. Its work is used to help clients run clinical programs more efficiently and bring medical treatments through development and approval pathways. Headquartered in Dublin, Ireland, ICON plc operates through a broad international network and serves organizations in multiple global markets.
WebsiteSouth County Business Park
Dublin, D18 X5R3
Ireland
The latest articles about ICLR.
Summary of Oct 28's posts. Generated by AI.
Summary of Feb 13's posts. Generated by AI.
Summary of Oct 28's posts. Generated by AI.
Investors talking about ICLR also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.